INS and type 1 diabetes mellitus: The standard therapy of T1D consists of the subcutaneous (SC) administration of exogenous insulin, through a basal-bolus strategy: basal insulin is administered to keep patient glycemia within the normal range between meals and overnight, while boluses are injected before and after meals to prevent post-prandial hyperglycemic events.